The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.
Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding .
Notice of Funding Opportunities
Title
Announcement Number
Activity Code
Clinical Trials Status
Expiration Date
Program Official
Sort descending
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
RFA-CA-24-009 (R33 Clinical Trial Not Allowed)
R33
Clinical Trial Not Allowed
10/02/2024
Guillermo Marquez, Ph.D.
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
RFA-CA-24-008 (R61 Clinical Trial Not Allowed)
R61
Clinical Trial Not Allowed
10/02/2024
Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research
RFA-CA-24-012 (R01 Clinical Trial Optional)
R01
Clinical Trial Optional
10/02/2024
Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research
RFA-CA-24-014 (P50 Clinical Trial Optional)
P50
Clinical Trial Optional
10/02/2024
Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research
RFA-CA-24-013 (U01 Clinical Trial Optional)
U01
Clinical Trial Optional
10/02/2024
Guillermo Marquez, Ph.D.
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes
PAR-22-131 (R01 Clinical Trial Optional)
R01
Clinical Trial Optional
09/08/2025
Richard Mazurchuk, Ph.D.
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research
PAR-22-099 (R01 Clinical Trial Optional)
R01
Clinical Trial Optional
05/08/2025
Richard Mazurchuk, Ph.D.
Notice of Intent to Publish a Funding Opportunity for The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research
NOT-CA-23-081 (K12 Clinical Trial Optional)
K12
Clinical Trial Optional
06/17/2024
Discovery and Development of Natural Products for Cancer Interception and Prevention
RFA-CA-23-028 (UG3/UH3 Clinical Trial Not Allowed)
UH3, UG3
Clinical Trial Not Allowed
06/14/2025
Altaf Mohammed, Ph.D.
Cancer Immunoprevention Network (CIP-Net) Research Projects
RFA-CA-23-029 (UG3/UH3 Clinical Trials Not Allowed)
UH3, UG3
07/04/2024
Altaf Mohammed, Ph.D.